[68] I first learned about this connection in my early days as a consulting pharmacist, working with people with developmental disabilities who had used various medications for epilepsy
Pharmacology 96 (1-2), 4954
In many areas, BPC-157 is marketed as research chemicals or not for human use, which means no typical labeling, batch testing, or regulation
Consumers Taking GLP-1s for Weight Loss, Current or Discontinued, Drive Lasting Changes in Retail, Per New Acosta Group Study News provided by Acosta Group Apr 14, 2025, 12:05 ET 76% of those who discontinued GLP-1s are eating the same amount or less and many report retaining healthy habits JACKSONVILLE, Fla., April 14, 2025 /PRNewswire/ -- In advance of the National Association of Chain Drug Stores (NACDS) Annual Meeting, Acosta Group is sharing the results of its recent proprietary GLP-1 Shopper Community study, focusing on consumers using the medications specifically to support weight loss
Discontinuation can be as high as 85% by the end of two years of treatment, according to a study conducted by Prime Therapeutics, a pharmacy benefit manager
In summary, various forms and durations of exercise interventions exert multidimensional and sustained benefits targeting core impairments in patients with NDDs, including cognitive deficits, motor dysfunction, and reduced quality of life